Symbol
APRE on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Ownership
682K shares
Security Ownership
9.9%

LYTTON LAURENCE W ownership in Aprea Therapeutics, Inc. Common Stock (APRE)

2025-11-17 - LYTTON LAURENCE W has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 682K shares of Aprea Therapeutics, Inc. Common Stock (APRE). This represents 9.9% percent ownership of the company.